| Detected | Trial | Change |
|---|---|---|
| 2026-05-20 | NCT07551544 ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed… |
overall status: "Not Yet Recruiting" → "Withdrawn" |
| 2026-05-20 | NCT07551544 ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed… |
Enrollment reduced: 688 -> 0 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04701151 | NORTH-REG Dwell-Time Study | Side Effect of Drug | Active, Not Recruiting |
| Phase 3 | |||
| NCT05037279 | Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and… | Bladder Cancer | Recruiting |
| NCT04165317 | A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer | Non-muscle Invasive Bladder Cancer | Active, Not Recruiting |
| NCT03528694 | Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy… | Non-muscle-invasive Bladder Cancer | Active, Not Recruiting |
| NCT03711032 | Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus… | High-risk Non-muscle Invasive Bladder Cancer | Active, Not Recruiting |
| NCT05538663 | Intravesical BCG vs GEMDOCE in NMIBC | Non-muscle-invasive Bladder Cancer | Active, Not Recruiting |
| NCT05943106 | BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants | Non-Muscle- Invasive Bladder Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT05947890 | Evaluating the Safety and Immunogenicity of MTBVAC | HIV I Infection | Recruiting |
| NCT07094711 | Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST) | Mycobacterium Avium-intracellulare Infection | Recruiting |
| NCT06833073 | A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer… | Urinary Bladder Neoplasms | Recruiting |
| NCT02081326 | Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes | Diabetes Mellitus, Type One | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT03317158 | Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive… | Urothelial Carcinoma | Recruiting |
| NCT02138734 | A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle… | Non-muscle Invasive Bladder Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07206225 | A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer | Non-muscle Invasive Bladder Cancer | Recruiting |
| NCT06050356 | First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b | Healthy | Active, Not Recruiting |